Number of Participants With Categorical Best Overall Response Start of Treatment up through 12 Months or Early Discontinuation [clinicaltrials_resource:7721594b823f0584de4c2456d262b8ec]
Best overall reponse based on investigator's disease status assessment. Complete response(CR)=disappearance of all target lesions.Partial Response(PR)=≥30% decrease in sum of longest dimensions of lesions taking as reference baseline sum longest dimensions.Progressive disease(PD)=≥20% increase in sum of longest dimensions of lesions taking as a reference smallest sum of longest dimensions since treatment start or appearance of ≥1 new lesions. Stable disease(SD)=neither shrinkage for PR or increase for PD taking as reference smallest sum of longest dimensions since treatment start.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Number of Participants With Categorical Best Overall Response Start of Treatment up through 12 Months or Early Discontinuation [clinicaltrials_resource:7721594b823f0584de4c2456d262b8ec]
Best overall reponse based on investigator's disease status assessment. Complete response(CR)=disappearance of all target lesions.Partial Response(PR)=≥30% decrease in sum of longest dimensions of lesions taking as reference baseline sum longest dimensions.Progressive disease(PD)=≥20% increase in sum of longest dimensions of lesions taking as a reference smallest sum of longest dimensions since treatment start or appearance of ≥1 new lesions. Stable disease(SD)=neither shrinkage for PR or increase for PD taking as reference smallest sum of longest dimensions since treatment start.
Bio2RDF identifier
7721594b823f0584de4c2456d262b8ec
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7721594b823f0584de4c2456d262b8ec
measure [clinicaltrials_vocabulary:measure]
Number of Participants With Categorical Best Overall Response
time frame [clinicaltrials_vocabulary:time-frame]
Start of Treatment up through 12 Months or Early Discontinuation
description
Best overall reponse based on ...... ensions since treatment start.
identifier
clinicaltrials_resource:7721594b823f0584de4c2456d262b8ec
title
Number of Participants With Ca ...... onths or Early Discontinuation
@en
type
label
Number of Participants With Ca ...... 1594b823f0584de4c2456d262b8ec]
@en